{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:14:16Z","timestamp":1778901256423,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,28]],"date-time":"2027-04-28T00:00:00Z","timestamp":1808870400000},"content-version":"am","delay-in-days":392,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"National Cancer Institute Division of Cancer Epidemiology and Genetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.euo.2025.07.008","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T21:13:04Z","timestamp":1757106784000},"page":"346-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Family History of Prostate, Breast, Ovarian, and\/or Pancreatic Cancer and Associations with Grade Reclassification in a Large Prostate Cancer Active Surveillance Cohort"],"prefix":"10.1016","volume":"9","author":[{"given":"Claire M.","family":"de la Calle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuezhou","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Fountain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean A.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mufaddal M.","family":"Mamawala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Landis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna J.","family":"Macura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara L.","family":"Lotan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce J.","family":"Trock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William B.","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian P.","family":"Pavlovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.07.008_b0005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2015.17703","article-title":"Familial risk and heritability of cancer among twins in Nordic countries","volume":"315","author":"Mucci","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.euo.2025.07.008_b0010","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/jnci\/86.21.1600","article-title":"Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands","volume":"86","author":"Goldgar","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euo.2025.07.008_b0015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/(SICI)1097-0142(19960101)77:1<138::AID-CNCR23>3.0.CO;2-5","article-title":"Familial prostate cancer in Sweden. A nationwide register cohort study","volume":"77","author":"Gronberg","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2025.07.008_b0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.eururo.2021.12.011","article-title":"Defining the impact of family history on detection of high-grade prostate cancer in a large multi-institutional cohort","volume":"82","author":"Clements","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.07.008_b0025","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/pros.2990170409","article-title":"Family history and the risk of prostate cancer","volume":"17","author":"Steinberg","year":"1990","journal-title":"Prostate"},{"key":"10.1016\/j.euo.2025.07.008_b0030","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/pros.20825","article-title":"Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era","volume":"68","author":"Chen","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.euo.2025.07.008_b0035","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.juro.2014.09.018","article-title":"Incorporation of detailed family history from the Swedish Family Cancer Database into the PCPT risk calculator","volume":"193","author":"Grill","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.07.008_b0040","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1200\/JCO.2017.76.6907","article-title":"Concordance of Non-low-risk disease among pairs of brothers with prostate cancer","volume":"36","author":"Jansson","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2025.07.008_b0045","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw110","article-title":"Family history and probability of prostate cancer, differentiated by risk category: a nationwide population-based study","volume":"108","author":"Bratt","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euo.2025.07.008_b0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/pros.23247","article-title":"Relative risks for lethal prostate cancer based on complete family history of prostate cancer death","volume":"77","author":"Albright","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.euo.2025.07.008_b0055","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/JU.0000000000002757","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline, part I: introduction, risk assessment, staging and risk-based management","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.07.008_b0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/JU.0000000000002758","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline, part II: principles of active surveillance, principles of surgery, and follow-up","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.07.008_b0065","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer\u20142024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.07.008_b0070","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.eururo.2021.12.007","article-title":"Systematic review of active surveillance for clinically localised prostate cancer to develop recommendations regarding inclusion of intermediate-risk disease, biopsy characteristics at inclusion and monitoring, and surveillance repeat biopsy strategy","volume":"81","author":"Willemse","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.07.008_b0075","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/JU.0000000000002668","article-title":"Association of family history of cancer with clinical and pathological outcomes for prostate cancer patients on active surveillance","volume":"208","author":"Jibara","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.07.008_b0080","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.euo.2023.02.014","article-title":"Is active surveillance an option for the management of men with low-grade prostate cancer and a positive family history? Results from a large, single-institution series","volume":"6","author":"Leni","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.07.008_b0085","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/JU.0000000000003396","article-title":"Impact of an expanded definition of family history on outcomes of active surveillance for prostate cancer","volume":"209","author":"Schneider","year":"2023","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.07.008_b0090","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bju.13862","article-title":"Prostate cancer family history and eligibility for active surveillance: a systematic review of the literature","volume":"120","author":"Telang","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.07.008_b0095","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.eururo.2019.12.017","article-title":"Active surveillance of grade group 1 prostate cancer: long-term outcomes from a large prospective cohort","volume":"77","author":"Tosoian","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.07.008_b0100","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/JU.0000000000000621","article-title":"African American race is not associated with risk of reclassification during active surveillance: results from the Canary Prostate Cancer Active Surveillance Study","volume":"203","author":"Schenk","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.07.008_b0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.7326\/M17-2792","article-title":"Scrutiny-dependent cancer and self-fulfilling risk factors","volume":"168","author":"Welch","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.euo.2025.07.008_b0110","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1001\/jama.2024.6695","article-title":"Long-term outcomes in patients using protocol-directed active surveillance for prostate cancer","volume":"331","author":"Newcomb","year":"2024","journal-title":"JAMA"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125002007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125002007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:35:39Z","timestamp":1778898939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931125002007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2588931125002007"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.07.008","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Family History of Prostate, Breast, Ovarian, and\/or Pancreatic Cancer and Associations with Grade Reclassification in a Large Prostate Cancer Active Surveillance Cohort","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}